• AIM: To explore the effect of miR-22 on viability, migration, invasion and apoptosis in retinoblastoma (RB) Y79 cells and to further detect the potential mechanism.
INTRODUCTION
R etinoblastoma (RB) is one of the most common intraocular malignant tumors in infants and young children. The incidence of RB is approximately one case in every 15 000 to 20 000 live births. Early detection and timely treatment of RB have led to a 95% survival rate in developed countries; however, in less developed countries the mortality rate is as high as 70% [1] [2] [3] . This may be in part due to delays in diagnosis, as most patients are diagnosed during the advanced stages of RB, especially in developing countries [4] . Despite improvements in RB treatment, the molecular mechanisms underlying its pathology are not fully understood. It is helpful to explore the molecular mechanisms of RB initiation in the design of new targeted therapy. miRNAs, short non-coding RNAs that regulate up to one third of protein-coding gene expression by inducing mRNA degradation or translational repression [5] [6] [7] [8] . miR-22, a 22
nucleotide non-coding RNA, is initially cloned in HeLa cells [9] and serves an essential role in a variety of cancers types [10] [11] . Recently, miR-22 was found to dysregulate in many kinds of cancer, being downregulated in glioblastoma [12] , gastric cancer [10] and hepatocellular carcinoma [13] , and upregulated in prostate cancer [14] . Moreover, miR-22 expression is downregulated in human RB, also in mouse and human RB cell lines [15] . However, the function and molecular mechanism of miR-22 are yet to be elucidated in RB. In addition, miR-22 has been reported to inhibit cell proliferation and migration through HMGB1 in osteosarcoma [11] . As an extracellular molecule, HMGB1 is implicated in cell differentiation, inflammation, cell migration and tumor progression by binding to advanced glycation end product receptors and Toll-like receptors [16] [17] . HMGB1 is overexpressed in various kinds of cancers including gastric cancer [18] , breast cancer and melanoma [19] [20] . Recent studies have demonstrated that HMGB1 is correlated with optic nerve invasion and poor differentiation in RB [21] . These findings motivated the examination of the role of miR-22 in HMGB1 expression in RB. In our present work, we investigated the role of miR-22 in viability, migration, invasion and apoptosis in RB Y79 cells and further detected the target gene HMGB1, with an attempt to provide novel treatment strategies to prevent the metastasis of RB.
MATERIALS AND METHODS Cell Culture
The human RB cell line Y79 was obtained from Beina Chuanglian Biotechnology Institute (Beijing, China). After resuscitation, the cells were preserved in RPMI1640 medium (Gibco, USA) containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin and were placed in a 37℃, 5% CO 2 incubator. We changed the medium every two to three days.
Construction of Plasmids and the Experiment Groups
The following eukaryotic plasmids were all constructed by the Gene Pharma Company (Shanghai, China). The present study used three groups in the stable transfection experiment with miR-22 overexpression: the normal control, negative control (GV251) and miR-22 overexpression transfection vector group (GV251/miR-22). Three groups were also designated in the stable transfection experiment with miR-22 RNA interference recombinant plasmid: the normal control, negative control (GV249) and miR-22 RNA interference recombinant plasmid (GV249/miR-22-siRNA). In addition, there were three groups in the stable transfection experiment with HMGB1 overexpression: the normal control, negative control (GV230) and HMGB1 overexpression transfection vector groups (GV230/HMGB1). Three groups were also designated in stable transfection experiment with HMGB1 RNA interference recombinant plasmid: the normal control, negative control (GV102) and HMGB1 RNA interference recombinant plasmid group (GV102/HMGB1-siRNA). There are RPMI1640 medium with 10% FBS in the lower chambers, and the filters of the chambers were coated with Matrigal (BD, USA). After 24h, invaded cells were at the bottom of the chambers, they were fixed with 4% paraformaldehyde and then stained with hematoxylin. Images were acquired by microscope (Nikon, Japan, ×200) and the cell numbers were counted in three different fields in every well. All the experiments were repeated in triplicate. Apoptosis Assay At 24h post-transfection, cells were trypsinized without ethylene diamine tetraacetic acid (EDTA) and washed using cold phosphate-buffered saline (PBS). FITCAnnexin V and propidium lodide (PI) were added to the cells, then the mixture was incubated for 15min in darkness at room temperature. The cellular apoptosis ratio was analyzed using the Annexin V-FITC apoptosis detection kit (BD Biosciences, San Diego, CA, USA).
RNA Extraction and Real-time Polymerase Chain Reaction
Total RNA from cultured cells was extracted using Trizol reagent (Invitrogen, USA). For miRNA reverse transcription (RT), an miRcute miRNA first-strand cDNA synthesis kit (Tiangen, China) was used. The expression level of miR-22 was quantified using an miRcute plus miRNA-qPCR Detection kit (Tiangen, China) and was normalized to U6 expression. The primer sequences were designed as follows: (U6) forward:
The common reverse primer used in this experiment was Uni-miRqRCR. Figure 1A ). Cell viability in the GV251/miR-22 group was markly decreased according to the CCK-8 assay, with inhibition rate was 11.71%±2.54% (12h), 21.36%±1.39% (24h) and 29.44%±1.15% (48h), respectively ( Figure 1B) . However, cellular apoptosis was higher in the GV251/miR-22 group (17.00%±0.39%) compared with the GV251 group (4.38%±0.38%, P<0.05; Figure 1C , 1D). To subsequently determine the effect of miR-22 on migration and invasion in Y79 cells, scratch and Transwell assays were performed. The cells in the GV251/miR-22 group had a lower migration rate ( Figure 1E, 1F) . Moreover, over-expression of miR-22 in the cells significantly decreased cell invasion (38.33%±4.11% vs 131.00%±3.56%, P<0.05; Figure 1G , 1H).
In conclusion, these results suggested that miR-22 promoted cell apoptosis and exhibited an inhibitory effect on viability, migration and invasion in Y79 cells.
miR-22 Negatively Regulated the Expression of Highmobility Group Box 1
To understand the mechanism of miR-22 in RB cells, we explored how the expression of HMGB1 was influenced by miR-22. miR-22 inhibited the mRNA and protein levels of HMGB1 in the GV251/miR-22 group ( Figure  2A-2C) . Furthermore, miR-22 expression was significantly attenuated in the GV249/miR-22-siRNA group compared with that in the control groups ( Figure 2D ). Moreover, HMGB1 expression was significantly elevated in the GV249/miR-22-siRNA group ( Figure 2E-2G ). Recent studies validated the hypothesis that miR-22 directly targets the 3'UTR of HMGB1 [11, 22] . Taken together, these data suggest that miR-22 has a negative regulation on the expression of HMGB1 in Y79 cells.
High-mobility Group Box 1 Silencing by shRNA Inhibited Viability, Migration and Invasion and Promotes Apoptosis
Next, we investigate the role of HMGB1 in Y79 cells, functional experiments were performed. Significant decrease of HMGB1 was observed in the GV102/HMGB1-siRNA group ( Figure 3A-3C) . The 12h post transfection, cell viability in the GV102/HMGB1-siRNA group was significantly decreased in the CCK-8 assay ( Figure 3D ). Cellular apoptosis was higher in the GV102/HMGB1-siRNA group compared with GV102 group (Figure 3E, 3F) . The cells in the GV102/HMGB1-siRNA group exhibited decreased rates of migration ( Figure  3G , 3H) and invasion ability ( Figure 3I, 3J) .
Upregulation of HMGB1 Rescued the Effect of miR-22
Overexpression on Viability, Migration, Invasion and Apoptosis A rescue experiment was conducted to elucidate the functional effects of miR-22 in Y79 cells. Transfected with GV230/HMGB1, Y79 cells exhibited increased expression of HMGB1 ( Figure 4A-4C) . Y79 cells were then co-transfected with GV251/miR-22 and GV230/HMGB1. The upregulation of HMGB1 partly reversed the effect on viability (after 12h), migration, invasion and apoptosis in Y79 cells induced by miR-22 overexpression (Figure 4D-4J ). These data suggested that miR-22 performed biological functions in part by targeting HMGB1 in Y79 cells. 
Biological Functions of miR-22 in Y79 Cells Mediated by the PI3K/AKT Signaling Pathway
To further clarify mechanism underlying the effect of miR-22 in Y79 cells on viability, migration, invasion and apoptosis, the level of p-AKT in the PI3K/AKT signaling pathway was examined. The expression level of p-AKT was significantly decreased in the GV251/miR-22 and GV102/HMGB1-siRNA groups compared with that in normal control group. Furthermore, p-AKT was markly enhanced in the GV230/HMGB1 group. Also, p-AKT was significantly elevated in group co-transfected with GV251/ miR-22 and GV230/HMGB1 compared with GV251/miR-22 group (Figure 5A , 5B). The collective results substantiate that miR-22 may serve a functional role in Y79 cells through HMGB1 and the PI3K/AKT signaling pathway may participate in the regulating process. DISCUSSION In recent years, accumulating studies have verified that miRNAs serve essential roles in the development of tumors. miRNAs participate in diverse biological functions, including differentiation, proliferation, apoptosis and metastasis [5] .
Recently, studies have reported that miRNAs can act as both tumor suppressors and tumor promoters [23] [24] . miR-22
inhibits the cell motility, invasion and proliferation in human glioblastoma [12] . Poor clinicopathologic characteristics and patient prognosis are associated with low expression of miR-22 in gastric cancer [10] . The prognosis, cell proliferation and tumourigenicity of hepatocellular carcinoma have been correlated with downregulated expression of miR-22 [13] . Recent study has shown that miR-22 was low expressed in human RB compared with normal retina [15] . However, the exact role of miR-22 in RB and its molecular mechanisms remain unclear.
Our present study examined the effects of miR-22 on the biological characteristics of the RB cell line Y79, through analysis of cell viability, migration, invasion and apoptosis. The present study found that the overexpression of miR-22 inhibited viability, migration and invasion while enhancing apoptosis in Y79 cells. A recent study reported that miR-22-transfected Y79 cells exhibited suppressed proliferation and reduced migration rate [25] . Therefore, miR-22 may function as a tumor suppressor in Y79 cells. As far as we know, this is the first study to confirm that miR-22 represses invasion and promotes apoptosis in Y79 cells. Similar results have been found in many cancers. For instance, it has been shown that miR-22 is downregulated and inhibits cell migration, invasion and growth in clear renal cell carcinoma [26] . Moreover, a recent study also demonstrated that miR-22 inhibited osteosarcoma cell migration and proliferation [11] . Recent studies have reported that miR-22 directly targets the 3'-UTR of HMGB1 [11, 22] . In order to further study the mechanisms of miR-22, the target gene HMGB1 was selected as a candidate gene. First, the association between miR-22 and HMGB1 was investigated in Y79 cells. The data demonstrated that the expression of miR-22 was negatively regulated the expression of HMGB1. Furthermore, viability, migration and invasion were significantly suppressed as a result of decreased HMGB1 expression, while apoptosis was increased. The results were consistent when miR-22 was overexpressed, as miR-22 overexpression downregulated the expression of HMGB1 in RB Y79 cells. Notably, expression of HMGB1 partially rescued the effects of miR-22 overexpression on cell viability, migration, invasion and apoptosis. This suggests that HMGB1, the target gene of miR-22, served an important role in Y79 cells, and that miR-22 may exert biological functions through HMGB1. A large amount of works have focused on the role of PI3K/ AKT signaling in various tumors. Recently, HMGB1 was found to regulate tumor metastasis by activating the PI3K/AKT signaling pathway in cutaneous squamous cell carcinoma [27] .
Other research has indicated that the PI3K/AKT signaling pathway plays a key role in HMGB1-induced mesangial cell proliferation [28] . To understand the exact mechanism of action of miR-22/HMGB1 in Y79 cells, the p-AKT level in this pathway was assessed. The present study demonstrated that HMGB1 silencing downregulated the degree of p-AKT, while overexpression of HMGB1 enhanced the activation of AKT in Y79 cells. This confirmed that the level of p-AKT was significantly downregulated in the miR-22 overexpression group, and this downregulation of p-AKT induced by miR-22 was partly rescued by HMGB1. These results suggested that miR-22 may exert biological functions on HMGB1 through an additional mechanism; the PI3K/AKT signaling pathway maybe involve in miR-22/HMGB1-induced viability, apoptosis, invasion and migration in Y79 cells.
In conclusion, these results suggested that miR-22 suppressed viability, migration and invasion while promoting apoptosis by targeting HMGB1 in RB Y79 cells. Furthermore, the PI3K/ AKT signaling pathway may involve in miR-22-induced changes of biological function. However, the role of miR-22 and HMGB1 in RB Y79 cells needs further investigation. 
